164 related articles for article (PubMed ID: 31312631)
1. Pilot Evaluation of a New Urine Progesterone Test to Confirm Ovulation in Women Using a Fertility Monitor.
Bouchard TP; Fehring RJ; Schneider M
Front Public Health; 2019; 7():184. PubMed ID: 31312631
[No Abstract] [Full Text] [Related]
2. Validation of urinary reproductive hormone measurements using a novel smartphone connected reader.
Pattnaik S; Das D; Venkatesan VA
Sci Rep; 2023 Jun; 13(1):9227. PubMed ID: 37286704
[TBL] [Abstract][Full Text] [Related]
3. Use of urinary pregnanediol 3-glucuronide to confirm ovulation.
Ecochard R; Leiva R; Bouchard T; Boehringer H; Direito A; Mariani A; Fehring R
Steroids; 2013 Oct; 78(10):1035-40. PubMed ID: 23831784
[TBL] [Abstract][Full Text] [Related]
4. Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase.
Usala SJ; Alliende ME; Trindade AA
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056427
[No Abstract] [Full Text] [Related]
5. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
7. Establishing a Gold Standard for Quantitative Menstrual Cycle Monitoring.
Bouchard T; Yong P; Doyle-Baker P
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763632
[No Abstract] [Full Text] [Related]
8. Complete Cycle Mapping Using a Quantitative At-Home Hormone Monitoring System in Prediction of Fertile Days, Confirmation of Ovulation, and Screening for Ovulation Issues Preventing Conception.
Wegrzynowicz AK; Beckley A; Eyvazzadeh A; Levy G; Park J; Klein J
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557055
[No Abstract] [Full Text] [Related]
9. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
10. Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1.
Leiva R; McNamara-Kilian M; Niezgoda H; Ecochard R; Bouchard T
BMJ Open; 2019 May; 9(5):e028496. PubMed ID: 31133596
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
12. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
13. The Fertility Indicator Equation Using Serum Progesterone and Urinary Pregnanediol-3-Glucuronide for Assessment of Ovulatory to Luteal Phase Transition.
Usala SJ; Alliende ME; Trindade AA
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33546226
[No Abstract] [Full Text] [Related]
14. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
15. The validation of the Billings ovulation method by laboratory research and field trials.
Billings JJ
Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
[TBL] [Abstract][Full Text] [Related]
16. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
[TBL] [Abstract][Full Text] [Related]
17. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women.
Direito A; Bailly S; Mariani A; Ecochard R
Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798
[TBL] [Abstract][Full Text] [Related]
18. Direct measurement of pregnanediol 3-glucuronide (PDG) in dried urine spots by liquid chromatography-mass spectrometry to detect ovulation.
Handelsman DJ; Nimmagadda R; Desai R; Handelsman TD; Whittle B; Skorupskaite K; Anderson RA
J Steroid Biochem Mol Biol; 2021 Jul; 211():105900. PubMed ID: 33872762
[TBL] [Abstract][Full Text] [Related]
19. Using Quantitative Hormone Monitoring to Identify the Postpartum Return of Fertility.
Bouchard TP; Schweinsberg K; Smith A; Schneider M
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004057
[No Abstract] [Full Text] [Related]
20. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
